AddLife AB (STU:1AD1) Total Equity: €525.8 Mil (As of Mar. 2026)


STU:1AD1 AddLife AB STU:1AD1
87 GF Score
Price €14.34
GF Value €13.28
! 5 Warning Signs
View Full Analysis

What is AddLife AB Total Equity?

AddLife AB STU:1AD1 +0.91% 87 Total Equity is €525.8 Mil as of Mar. 2026. GuruFocus rates STU:1AD1 with a GF Score™ of 87/100 and a GF Value™ of €13.28. The stock has 5 warning signs investors should review.

AddLife AB's total equity for the quarter that ended in Mar. 2026 was €525.8 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

AddLife AB Total Equity Historical Data

* Premium members only.

The historical data trend for AddLife AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AddLife AB Total Equity Chart

AddLife AB Annual Data
Trend Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 417.79 452.17 443.41 461.55 500.54

AddLife AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 467.48 478.35 482.51 500.54 525.84
STU:1AD1
87GF Score
AddLife AB STU:1AD1
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AddLife AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

AddLife AB's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1168.042-667.505
=500.5

AddLife AB's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1207.836-681.996
=525.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €525.8 Mil mean?
AddLife AB (STU:1AD1) has a Total Equity of €525.8 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for AddLife AB and its competitors.
Is AddLife AB's Total Equity too high?
AddLife AB's current Total Equity is €525.8 Mil. Overall, AddLife AB has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's Total Equity compare to ISRG and BDX?
AddLife AB's Total Equity of €525.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for AddLife AB and its competitors. AddLife AB's current Total Equity is €525.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
AddLife AB (STU:1AD1) has a current Total Equity of €525.8 Mil. The stock's GF Value™ is €13.28, compared to a current price of €14.34 — trading 8% above its estimated fair value. The current Total Equity is €525.8 Mil. AddLife AB's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For AddLife AB (STU:1AD1), the current Total Equity is €525.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AddLife AB (STU:1AD1) Overvalued in 2026?

Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued. The current stock price of €14.34 is trading 8% above its estimated GF Value™ of €13.28.

Key valuation signals for STU:1AD1:

  • Total Equity: €525.8 Mil
  • GF Value™: €13.28 vs. price of €14.34 (8% above fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the STU:1AD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AddLife AB Business Description

Address Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
87GF Score

Get the complete analysis for STU:1AD1

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.34
Price
€13.28
GF Value